CClinicalTrials.gg
Status unknownNCT05233280Updated Feb 18, 2022

Early Versus Delayed Oral Liquids and Soft Food After Elective Ceasarean Section

An observational study in Prevent Postopertive Nausea and Vomiting, sponsored by Ain Shams University. Status unknown. Open to female participants aged 17 Years to 50 Years. Per ClinicalTrials.gov, last updated 2022-02-18.

Sponsored by Ain Shams University · Observational

The sponsor has not verified this record recently (last verified Dec 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
17 Years to 50 Years
Sex
Female
01

Study summary

To compare the safety of early versus delayed oral feeding after uncomplicated cesarean section under spinal anesthesia

Read the detailed description

Cesarean section is one of most common surgical procedures saving both for mother and newborn when medically indicated .traditionally patients are not given fluids or food afer abdominal surgery until bowel function return as evidenced by bowel sounds passage of flatus or stool or feeling of hunger the rationale of this practice is to prevent postoperative nausea , vomiting, distension and other complications

02

Conditions studied

  • Prevent Postopertive Nausea and Vomiting

Browse trials for

03

In context

Vomiting

1,100 studies on the registry are indexed under Vomiting; 134 are open to participants now.

This study's planned enrollment of 150 is close to the median of 160 across 124 observational studies indexed under Vomiting.

Browse Vomiting studies →

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 50 Years
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

Women in child bearing period

Inclusion criteria

  • previous 1,2,3 cs Uncomplicated elective cs Singletone pregnancy Spinal anesthesia

Exclusion criteria

Exclusion Criteria:

  • women with medical disorder HTN, DM History of bowel surgery or intraoprative complication Contraindication to spinal anesthesia
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group A

    Early feeding group

    Other: Oral liquids and soft food 2 hours postoperative

  • Group B

    Delayed feeding group

Interventions

  • OtherOral liquids and soft food 2 hours postoperative

    Early versus delayed oral liquid feeding after ceasarean section

06

What researchers measure

Primary outcomes

  1. Time of passage of flatus

    Time frame: 6 hrs

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05233280
Lead sponsor
Ain Shams University
Responsible party
Sponsor
First posted
Feb 10, 2022
Start date
Feb 20, 2022 (estimated)
Primary completion
Mar 15, 2022 (estimated)
Completion
Apr 15, 2022 (estimated)
Last update
Feb 18, 2022

Study contacts

Yousra Abdelsattar
Contact
Yosraabdelsatar@gmail.com
01001115045
Magdy Kolib
Contact
01200520050

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion